Mission

SINGAPORE SCIENCES
 
is headquartered
​ 
in Singapore,
 
Asia's Healthcare Hub.
SINGAPORE SCIENCES is a biopharmaceutical company that develops research-based, clinically tested healthcare products that addresses chronic diseases. Our portfolio and pipeline spanning endocrinology (diabetes), immunology and oncology, our goal is to use the most innovative approach in developing therapeutic products of the highest quality, to change the way how diseases such as diabetes, immune deficiencies and cancer are prevented and treated.
​​
Built upon a foundation grounded in scientific evidence, 
​SINGAPORE SCIENCES is recognized as the leader in the field of novel healthcare research & product developments. 

Each year SINGAPORE SCIENCES sponsors numerous research projects in leading institutes in Singapore and internationally on cutting edge research, including double-blind, placebo-controlled studies proving the safety and efficacy of its premier products.

Our R&D Initiatives and Collaborators: